Explore the Global Methotrexate Drug Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Methotrexate Drug Market

Key Insight

Methotrexate drug sales will expand through 2036, with psoriasis holding 15% of the indication segment in 2026. The market was valued at USD 655.5 million in 2025 and is expected to be worth USD 1181.27 million by 2036, creating an incremental opportunity of USD 489.72 million between 2026 and 2036.

May 21, 2026

Anurag Sharma

315 Pages

Cite this Report

Methotrexate Drug Market

https://www.futuremarketinsights.com/reports/methotrexate-drug-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Amneal Pharmaceuticals LLC
Aspen Pharmacare Holdings Limited
Fresenius Kabi AG
Hikma Pharmaceuticals PLC
Mylan N.V
The Vanguard Group
Sandoz International GmbH
Sun Pharmaceutical Industries Ltd
Berkshire Hathaway

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Methotrexate Drug Market

Key Players

Similar Industry Reports